logo-large
  • Browse Categories

Publications by authors named "Gale Cupp"

Claim this Profile
T
Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.
Steven J Lichtenstein, Liberation De Leon, Warren Heller, Bonnie Marshall, Gale Cupp

J Pediatr Ophthalmol Strabismus· July 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.
Shachar Tauber, Gale Cupp, Richard Garber, John Bartell, Firoz Vohra

Adv Ther· July 2011


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
David W Stroman, Joseph J Dajcs, Gale A Cupp, Barry A Schlech

Surv Ophthalmol· November 2005


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: